EUVIMEDEUVIMED entdecken
Crossref

Intelligent detection of chronic kidney disease using machine learning: A comparative evaluation with nested cross-validation

Huda Dham Bader iD, Noora Mazin Sheet iD, Alyaa Farouk Al-Omari iD

Technology and Health Care · 18.11.2026

DOI: 10.1177/09287329261507156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, online erschienen am 18.11.2026. Verfasst von Huda Dham Bader und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physiology, College of Medicine, University of Mosul, Mosul, Iraq. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is progressive, and early diagnosis improves outcomes.

Objective

We assessed how reliably routine clinical and laboratory variables identify CKD, and whether differences between common classifiers exceed the sampling error of a 400-patient dataset.

Methods

We analysed the UCI CKD dataset (250 CKD and 150 non-CKD patients, 24 predictors) with ten classifiers: logistic regression (LR), K-nearest neighbours (KNN), decision tree (DT), random forest (RF), AdaBoost, support vector machine (SVM), gradient boosting (GB), extra trees (ETs), XGBoost and LightGBM. A majority-class baseline served as reference. Imputation (KNN, k = 5), scaling and hyperparameter search were fitted inside the training folds of a nested, repeated stratified 5-fold cross-validation (CV) (three repeats). We report mean ± SD with Nadeau–Bengio 95% confidence intervals and compared models with corrected paired t -tests and Holm adjustment.

Results

Nine classifiers reached a cross-validated accuracy of 98.25–99.50% (AUC ≥ 0.990); KNN reached 93.33% and the baseline 62.50%. LightGBM (99.50 ± 0.63%), RF (99.42 ± 0.80%) and XGBoost (99.25 ± 0.79%) had the highest mean accuracy, but no pair among the nine non-KNN classifiers differed significantly. Permutation importance and SHAP highlighted specific gravity, haemoglobin, serum creatinine, albumin and packed cell volume.

Conclusion

No classifier could be ranked above another. The data come from one public dataset with almost completely separable classes, so external validation is needed.

Schlagwörter

Stichwörter der Autor:innen

Chronic kidney diseaseartificial intelligence in medicinedisease classificationexplainable AI (SHAP)machine learning in healthcarenested cross-validation

Autor:innen und Institutionen

  • Department of Medical Physiology, College of Medicine, University of Mosul, Mosul, Iraq.
  • Ninevah University, Office of the Scientific Assistant, Registration and Student Affairs Department, Mosul, Iraq.

ORCID-Profile: Huda Dham Bader, Noora Mazin Sheet, Alyaa Farouk Al-Omari

Zitieren

APA

Bader, H. D., Sheet, N. M., & Al-Omari, A. F. (2026). Intelligent detection of chronic kidney disease using machine learning: A comparative evaluation with nested cross-validation. Technology and Health Care. https://doi.org/10.1177/09287329261507156

Vancouver

Bader HD, Sheet NM, Al-Omari AF. Intelligent detection of chronic kidney disease using machine learning: A comparative evaluation with nested cross-validation. Technology and Health Care. 2026. doi:10.1177/09287329261507156

BibTeX
@article{Bader2026,
  author = {Bader, Huda Dham and Sheet, Noora Mazin and Al-Omari, Alyaa Farouk},
  title = {Intelligent detection of chronic kidney disease using machine learning: A comparative evaluation with nested cross-validation},
  journal = {Technology and Health Care},
  year = {2026},
  doi = {10.1177/09287329261507156}
}
Kostenlos starten →